Jim Januzzi is a senior clinician at the Massachusetts General Hospital, where he is the Hutter Family Professor of Medicine at Harvard and Director of Heart Failure and Biomarker Trials at the Baim Institute for Clinical Research. Dr. Januzzi has extensive background in clinical trials of heart failure therapeutics, including conventional therapies such as sacubitril/valsartan and SGLT2 inhibitors as well as emerging/novel therapies.